Drug Discovery World

MARCH 13, 2024

According to Statista, revenue in this sector is expected to grow at an annual rate of 6.77%, resulting in a market volume of US$2,208m by 2028 1. Another successful NUS spin-out is RNA company Ephyra, now based in Cambridge, England, which is developing a new class of therapeutics known as designer sponge RNAs.

Government 173

Government Science Pharmaceuticals Vaccine 173

Drug Discovery World

SEPTEMBER 28, 2022

In fact, the market research firm, Bekryl, predicts that AI has the potential to offer over $70 billion in savings for the drug discovery process by 2028. . The AI Drug Development Division is focused on AI-guided design and development of individualised neoantigen vaccines in oncology. . Looking ahead, the future is bright.

Pharma Companies 130

Pharma Companies Hospitals Clinical Trials Drugs 130

Drug Discovery World

AUGUST 8, 2023

The India Brand Equity Foundation confirms that India is the largest provider of generic drugs globally and is known for its affordable vaccines and generic medications 1. India will make its mark as a growing market, potential competitor or partner in manufacturing and R&D, and as a location for clinical trials.”

Research 130

Research Pharmacy Pharmaceuticals Government 130

Codon

SEPTEMBER 29, 2024

But, regardless of which was first, they all operated with the same core data as their mechanism for understanding life: messenger RNA ( mRNA ). 2028 Over the next year, the scientific community ferociously interrogated the model. The average pass rate of phase I trials went up by 5 percent.

Engineering 125

Engineering Virus DNA Therapies 125